Status
Conditions
Treatments
About
This study aims to analyze the expression of micro-RNA (miRNA) and long non-coding RNA (lncRNA) by next-generation sequencing in patients with high grade serous ovarian cancer (HGSOC) and benign gynecologic diseases. The candidate miRNA/lncRNA will be validated as biomarker for the detection and prognosis of HGSOC.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
160 participants in 2 patient groups
Loading...
Central trial contact
Lei Li, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal